Mitchell Gold
Founder at Alpine Bioventures, GP, LLC
Profile
Mitchell H.
Gold was the founder of Alpine Biosciences, Inc. (founded in 2012) where he served as Chairman from 2012 to 2014.
He is also the founder of Elixis, Inc. (founded in 1995) where he held the title of President & Chief Executive Officer from 1995 to 2000.
Dr. Gold is also the founder of Alpine Bioventures, GP, LLC.
Dr. Gold's current job(s) include being a Director at the Prostate Cancer Institute, the Washington Biotechnology & Biomedical Association, the University of Washington, and a Member-Governors Board at the Biotechnology Innovation Organization.
Dr. Gold's former job(s) include being an Executive Chairman & Chief Executive Officer at Alpine Immune Sciences, Inc., a Director at Dendreon Corp., SillaJen Biotherapeutics, Inc., and the Fred Hutchinson Cancer Research Center, as well as being the VP-Business Development, Sales & Marketing at Data Critical Corp.Dr. Gold's education history includes an undergraduate degree from the University of Wisconsin and a graduate degree from Rush Medical College.
Mitchell Gold active positions
| Companies | Position | Start |
|---|---|---|
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Director/Board Member | - |
| Washington Biotechnology & Biomedical Association | Director/Board Member | - |
| Prostate Cancer Institute | Director/Board Member | 2009-07-22 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | - |
Alpine Bioventures, GP, LLC
 Alpine Bioventures, GP, LLC Investment ManagersFinance Alpine Bioventures, GP, LLC (Alpine Bioventures) is a venture capital firm founded by Mitchell H. Gold in 2013. The firm is headquartered in Seattle, Washington. | Founder | - |
Former positions of Mitchell Gold
| Companies | Position | End |
|---|---|---|
| ALPINE IMMUNE SCIENCES, INC. | Chief Executive Officer | 2024-05-19 |
Alpine Biosciences, Inc.
 Alpine Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Alpine Biosciences, Inc. provided research and development of protocells for treatment of rare diseases and cancer. The company was headquartered in Seattle, WA. | Founder | 2013-12-31 |
| DENDREON CORPORATION | Chief Executive Officer | 2011-12-31 |
Data Critical Corp.
 Data Critical Corp. Packaged SoftwareTechnology Services Data Critical Corp. manufactures and supports open personal information communications applications. The company is based in Bothell, WA. The company was founded by David E. Albert. Data Critical was acquired by GE Medical Systems, Inc. on September 25, 2001 for $67.35 million. | Sales & Marketing | 2001-04-30 |
| ░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
Training of Mitchell Gold
| University of Wisconsin | Undergraduate Degree |
| Rush Medical College | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ALPINE IMMUNE SCIENCES, INC. | Health Technology |
| Private companies | 11 |
|---|---|
Data Critical Corp.
Data Critical Corp. Packaged SoftwareTechnology Services Data Critical Corp. manufactures and supports open personal information communications applications. The company is based in Bothell, WA. The company was founded by David E. Albert. Data Critical was acquired by GE Medical Systems, Inc. on September 25, 2001 for $67.35 million. | Technology Services |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
SillaJen Biotherapeutics, Inc.
 SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA. | Commercial Services |
Alpine Immune Sciences, Inc. /Old/
 Alpine Immune Sciences, Inc. /Old/ BiotechnologyHealth Technology Alpine Immune Sciences, Inc. operates as a biotechnology company which develops cancer immunotherapy systems. The firm provides immunotherapy and immune synapse solutions. The company was founded by Ryan Swanson and Michael Kornacker in 2015 and is headquartered in Seattle, WA. | Health Technology |
Elixis, Inc.
 Elixis, Inc. Packaged SoftwareTechnology Services Elixis, Inc. develops internet-based healthcare applications. The American company was founded by Mitchell H. Gold, Edward M. Boyle. Elixis was acquired by Data Critical Corp. on April 04, 2000 for $2.44 million. | Technology Services |
Fred Hutchinson Cancer Research Center
 Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Fred Hutchinson Cancer Research Center is a non-profit organization which provides research and testing services. The company was founded in 1965 and is headquartered in Seattle, WA. | Commercial Services |
| Washington Biotechnology & Biomedical Association | |
| Prostate Cancer Institute | |
Alpine Biosciences, Inc.
Alpine Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Alpine Biosciences, Inc. provided research and development of protocells for treatment of rare diseases and cancer. The company was headquartered in Seattle, WA. | Commercial Services |
Alpine Bioventures, GP, LLC
Alpine Bioventures, GP, LLC Investment ManagersFinance Alpine Bioventures, GP, LLC (Alpine Bioventures) is a venture capital firm founded by Mitchell H. Gold in 2013. The firm is headquartered in Seattle, Washington. | Finance |
- Stock Market
- Insiders
- Mitchell Gold
